Friedman, Claire F <br/><br/>
Emerging Tissue and Blood-Based Biomarkers that may Predict Response to Immune Checkpoint Inhibition.  [electronic resource] 

 -  Current oncology reports  Apr 2016 
 - 21 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review 
<br/><br/><label>ISSN: </label>1534-6269 
<br/><br/><label>Standard No.: </label>10.1007/s11912-016-0509-x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies--immunology<br/>Antibodies, Monoclonal--therapeutic use<br/>Antibodies, Monoclonal, Humanized--therapeutic use<br/>B7-H1 Antigen--blood<br/>Biomarkers, Tumor--blood<br/>CTLA-4 Antigen--blood<br/>Humans<br/>Immunotherapy<br/>Ipilimumab<br/>Melanoma--blood<br/>Nivolumab<br/>Programmed Cell Death 1 Receptor--blood<br/>Tumor Microenvironment--immunology